iFCG yields unprecedented MRD negativity in CLL

FCR chemoimmunotherapy is most effective in the IGVH mutated, non-17p deletion chronic lymphocytic leukemia (CLL) patient subgroup. With the advent of novel drugs in the field however, Nitin Jain, MD,... Author: VJHemOnc Added: 09/21/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts